You are here

  • Home
  • Archive
  • Volume 89, Issue 12
  • Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years

Article metrics

Article menu

Download PDFPDF

Neuropsychiatry
Research paper
Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years

 

Online download statistics by month:

Online download statistics by month: August 2018 to March 2024

AbstractFullPdf
Aug 2018962993189
Sep 201859660295
Oct 201821421435
Nov 201835835783
Dec 201824924858
Jan 201919118758
Feb 2019888628
Mar 2019117111124
Apr 20191069721
May 20191029924
Jun 2019949019
Jul 201911810833
Aug 201911611515
Sep 201910210118
Oct 201912111130
Nov 2019908936
Dec 2019898618
Jan 2020908328
Feb 2020878227
Mar 2020797627
Apr 202017716016
May 2020797740
Jun 2020767550
Jul 2020878333
Aug 2020938664
Sep 2020969521
Oct 2020969417
Nov 2020958831
Dec 202026725827
Jan 202120619725
Feb 20211049614
Mar 202114913720
Apr 202127627127
May 202122621130
Jun 202124524629
Jul 202130831223
Aug 202133934125
Sep 202128328231
Oct 202136335130
Nov 202123123630
Dec 202131532519
Jan 202224524424
Feb 202245046243
Mar 202249649815
Apr 202252151937
May 202241240236
Jun 202228028519
Jul 202234034130
Aug 202228428720
Sep 202228228129
Oct 202231229932
Nov 202222322320
Dec 202221220522
Jan 202322823226
Feb 202328228318
Mar 202323523837
Apr 202325925541
May 202322622318
Jun 202322422717
Jul 202320520417
Aug 202323222915
Sep 202324424422
Oct 202332532316
Nov 202341541918
Dec 202317317117
Jan 2024494234
Feb 202415814426
Mar 2024203196151
Total15595154322368